A Review of Autologous Islet Transplantation
Overview
Authors
Affiliations
Autologous islet transplantation after total or semitotal pancreatectomy aims to preserve insulin secretory function and prevent the onset of diabetes. The major indication for pancreatectomy is chronic pancreatitis with severe abdominal pain, a benign pancreatic tumor, and trauma. The metabolic outcome of autologous islet transplantation is better than that of allogeneic transplantation and depends on the number of transplanted islets. Achieving islet isolation from a fibrous or damaged pancreas is one of the biggest challenges of autologous islet transplantation; a major complication is portal vein thrombosis after crude islet infusion. However, the incidence of portal vein thrombosis has decreased as islet preparation techniques have improved over time.
Burke J, Zhu Y, Zhang X, Rios P, Joshi I, Lopez D Sci Adv. 2024; 10(23):eadk3081.
PMID: 38848367 PMC: 11160476. DOI: 10.1126/sciadv.adk3081.
Total Pancreatectomy with Autologous Islet Cell Transplantation-The Current Indications.
Jablonska B, Mrowiec S J Clin Med. 2021; 10(12).
PMID: 34202998 PMC: 8235694. DOI: 10.3390/jcm10122723.
Wang H, Gou W, Strange C, Wang J, Nietert P, Cloud C Cell Transplant. 2019; 28(1_suppl):25S-36S.
PMID: 31885286 PMC: 7016471. DOI: 10.1177/0963689719890596.
Robbins A, Skube M, Bellin M, Dunn T, Chapman S, Berry K Pancreas. 2019; 48(10):1329-1333.
PMID: 31688597 PMC: 7181460. DOI: 10.1097/MPA.0000000000001421.